ÂÜÀòÂÒÂ×

Dr. Omid Veiseh is a Co-Founder of Avenge Bio and an Assistant Professor and CPRIT Scholar in Cancer Research in the Department of Bioengineering at Rice University. He received a dual Ph.D. in Materials Science & Engineering and Nanotechnology from the University of Washington. Dr. Veiseh completed his postdoctoral research with Prof. Robert Langer and Prof. Daniel Anderson at MIT and Harvard Medical School. Over the course of his career he has authored, or co-authored more than 50 peer-reviewed publications including those in Nature, Nature Biotechnology, Nature Materials, Nature Medicine, and is an inventor on 20 pending or awarded patents, many of which have been licensed for commercialization by 3 separate biotechnology companies. He is Co-Founder of Sigilon Therapeutics. Throughout his career he has received numerous awards and fellowships including: a $2 million CPRIT Scholar In Cancer Research Award from the state of Texas, and was named one of MedTech Boston’s 40 Under 40 Healthcare Innovators for 2017.